ERBB2 and neoplasm: Overexpression of HER2 can be heterogeneously distributed in both, the primary tumor as well as in metastases (Fig. 2), and is more commonly found in proximal and intestinal type GCs, respectively (Warneke et al. 2013a, b; Roviello et al. 2022).